Skip to main content
915 TLDR
Health
1 read

Trump Signs Order to Boost Research on Psychedelic Treatments for Mental Health

KVIACNN Newsource
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KVIA

Read Original

AI Summary

President Donald Trump has signed an executive order to promote research into psychedelic drugs, particularly ibogaine, as potential treatments for severe mental health issues. The federal government will invest $50 million to expedite research, aiming to address the mental health crisis affecting veterans and others. Trump humorously expressed interest in trying ibogaine himself, while Health and Human Services Secretary Robert F. Kennedy Jr. emphasized the need for faster approval processes for these therapies. Although initial studies show promise, experts warn about the risks associated with psychedelics and the need for rigorous research standards.

Key Details: • Executive order signed to enhance research on psychedelics, especially ibogaine. • $50 million allocated for research funding. • FDA approval timeline for psychedelic treatments could be reduced to weeks. • Ibogaine is currently classified as a Schedule I substance with potential risks.

trump mental-health fda psychedelics ibogaine

People & Organizations

Donald TrumpFDARobert F. Kennedy Jr.Joe RoganHealth and Human Services

Related Articles